Cannabis Science Celebrates the Lives and Mourns the Loss of Dr. Allen Herman and The Honorable Ronald V. Dellums
August 08, 2018 09:10 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, celebrates the lives of Dr. Allen Herman,...
Cannabis Science and FSO NAC Sign for New 100-Acre Property in Minden, Nevada as the Industrial Hemp Research Projects in Nevada Continue to Flourish for the Group
July 24, 2018 12:05 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 24, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the signing of...
Cannabis Science Research Group FSO NAC / HRM Farms Receives Approvals From the Nevada Department of Agriculture for its Newest 40-Acre Industrial Hemp Research Project in Nevada
July 10, 2018 07:35 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the immediate...
Cannabis Science, Harvard Medical School’s Global Health Catalyst, Elpasso Farms (South Africa), and American States University Partner to Strengthen Africa’s Economic and Healthcare Infrastructure
July 09, 2018 08:43 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce Harvard...
Cannabis Science’s University Scholarship Expo Begins This Weekend; Register Now at the Company’s Flagship Location: CBIS Cali Rx, 14006 Ventura Boulevard, Sherman Oaks, CA
June 08, 2018 11:53 ET
|
Cannabis Science, Inc.
IRVINE, CA, June 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the...
Phase I Underway, Cannabis Science 1,000–Acre Elpasso Farms Economic Development Plan in South Africa; Agriculture, Food Security, Phytomedicines, with an Emphasis on Micro-Nutrients, and Education
June 05, 2018 08:16 ET
|
Cannabis Science, Inc.
Pan African Ambassador for Food Security, Dr. Brylyne Chitsunge, Owner of Elpasso Farms Joins Cannabis Science Scientific Advisory Board IRVINE, CA, June 05, 2018 (GLOBE NEWSWIRE) -- Cannabis...
Cannabis Science CEO Receives Prestigious Industry Leader Award at 2018 Global Health Catalyst Summit at Harvard Medical School and Announces Major Collaboration With Elpasso Farms in South Africa
May 29, 2018 07:48 ET
|
Cannabis Science, Inc.
BOSTON, MA, May 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company has...
Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MA
May 14, 2018 07:41 ET
|
Cannabis Science, Inc.
IRVINE, CA, May 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that Mr. Raymond C. Dabney,...
Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers
May 01, 2018 07:44 ET
|
Cannabis Science, Inc.
IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the second publication...
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
April 27, 2018 10:49 ET
|
Cannabis Science, Inc.
IRVINE, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali RX, are...